| UniProt ID | DPM1_HUMAN | |
|---|---|---|
| UniProt AC | O60762 | |
| Protein Name | Dolichol-phosphate mannosyltransferase subunit 1 | |
| Gene Name | DPM1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 260 | |
| Subcellular Localization | Endoplasmic reticulum. | |
| Protein Description | Transfers mannose from GDP-mannose to dolichol monophosphate to form dolichol phosphate mannose (Dol-P-Man) which is the mannosyl donor in pathways leading to N-glycosylation, glycosyl phosphatidylinositol membrane anchoring, and O-mannosylation of proteins; catalytic subunit of the dolichol-phosphate mannose (DPM) synthase complex.. | |
| Protein Sequence | MASLEVSRSPRRSRRELEVRSPRQNKYSVLLPTYNERENLPLIVWLLVKSFSESGINYEIIIIDDGSPDGTRDVAEQLEKIYGSDRILLRPREKKLGLGTAYIHGMKHATGNYIIIMDADLSHHPKFIPEFIRKQKEGNFDIVSGTRYKGNGGVYGWDLKRKIISRGANFLTQILLRPGASDLTGSFRLYRKEVLEKLIEKCVSKGYVFQMEMIVRARQLNYTIGEVPISFVDRVYGESKLGGNEIVSFLKGLLTLFATT | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MASLEVSRS ------CCCCCCCCC | 23.87 | 22814378 | |
| 3 | Phosphorylation | -----MASLEVSRSP -----CCCCCCCCCC | 24.62 | 25159151 | |
| 7 | Phosphorylation | -MASLEVSRSPRRSR -CCCCCCCCCCCCCC | 20.05 | 29255136 | |
| 9 | Phosphorylation | ASLEVSRSPRRSRRE CCCCCCCCCCCCCCE | 18.43 | 29255136 | |
| 13 | Phosphorylation | VSRSPRRSRRELEVR CCCCCCCCCCEEEEC | 36.65 | 17081983 | |
| 21 | Phosphorylation | RRELEVRSPRQNKYS CCEEEECCCCCCCCE | 29.61 | 25159151 | |
| 26 | Ubiquitination | VRSPRQNKYSVLLPT ECCCCCCCCEEEECC | 30.48 | 21890473 | |
| 26 | Ubiquitination | VRSPRQNKYSVLLPT ECCCCCCCCEEEECC | 30.48 | 21890473 | |
| 27 | Phosphorylation | RSPRQNKYSVLLPTY CCCCCCCCEEEECCC | 16.15 | 28152594 | |
| 28 | Phosphorylation | SPRQNKYSVLLPTYN CCCCCCCEEEECCCC | 14.11 | 28152594 | |
| 33 | Phosphorylation | KYSVLLPTYNERENL CCEEEECCCCHHCCC | 38.66 | 28152594 | |
| 34 | Phosphorylation | YSVLLPTYNERENLP CEEEECCCCHHCCCC | 17.06 | 28152594 | |
| 58 | Phosphorylation | FSESGINYEIIIIDD HHHCCCCEEEEEECC | 13.44 | 25332170 | |
| 71 | Phosphorylation | DDGSPDGTRDVAEQL CCCCCCCCHHHHHHH | 30.95 | 25332170 | |
| 80 | Ubiquitination | DVAEQLEKIYGSDRI HHHHHHHHHHCCCCE | 50.23 | 21890473 | |
| 80 | Ubiquitination | DVAEQLEKIYGSDRI HHHHHHHHHHCCCCE | 50.23 | 21890473 | |
| 82 | Phosphorylation | AEQLEKIYGSDRILL HHHHHHHHCCCCEEE | 22.96 | 29496907 | |
| 95 | Ubiquitination | LLRPREKKLGLGTAY EECCCHHCCCCCCHH | 42.93 | 21890473 | |
| 95 | Ubiquitination | LLRPREKKLGLGTAY EECCCHHCCCCCCHH | 42.93 | 21890473 | |
| 100 | Phosphorylation | EKKLGLGTAYIHGMK HHCCCCCCHHHCCCC | 22.72 | 25404012 | |
| 102 | Phosphorylation | KLGLGTAYIHGMKHA CCCCCCHHHCCCCCC | 8.03 | 25404012 | |
| 110 | Phosphorylation | IHGMKHATGNYIIIM HCCCCCCCCCEEEEE | 26.19 | 25404012 | |
| 113 | Phosphorylation | MKHATGNYIIIMDAD CCCCCCCEEEEEECC | 8.54 | 25404012 | |
| 136 | Ubiquitination | PEFIRKQKEGNFDIV HHHHHHHCCCCEEEC | 71.30 | - | |
| 136 | Malonylation | PEFIRKQKEGNFDIV HHHHHHHCCCCEEEC | 71.30 | 26320211 | |
| 149 | Ubiquitination | IVSGTRYKGNGGVYG ECCCCEEECCCCEEC | 42.48 | 21890473 | |
| 149 | Ubiquitination | IVSGTRYKGNGGVYG ECCCCEEECCCCEEC | 42.48 | 21890473 | |
| 149 | Methylation | IVSGTRYKGNGGVYG ECCCCEEECCCCEEC | 42.48 | - | |
| 155 | Phosphorylation | YKGNGGVYGWDLKRK EECCCCEECCCHHHH | 18.77 | 29496907 | |
| 160 | Ubiquitination | GVYGWDLKRKIISRG CEECCCHHHHHHHHC | 49.53 | 21890473 | |
| 172 | Phosphorylation | SRGANFLTQILLRPG HHCCCHHHHHHHCCC | 14.93 | 29978859 | |
| 174 | Acetylation | GANFLTQILLRPGAS CCCHHHHHHHCCCCC | 3.09 | 19608861 | |
| 197 | Acetylation | YRKEVLEKLIEKCVS HCHHHHHHHHHHHHH | 51.07 | 19608861 | |
| 232 | Ubiquitination | GEVPISFVDRVYGES CCCCCCHHHHHHCCC | 3.52 | 19608861 | |
| 232 | Acetylation | GEVPISFVDRVYGES CCCCCCHHHHHHCCC | 3.52 | 19608861 | |
| 234 | Methylation | VPISFVDRVYGESKL CCCCHHHHHHCCCCC | 20.46 | - | |
| 236 | Ubiquitination | ISFVDRVYGESKLGG CCHHHHHHCCCCCCH | 18.97 | - | |
| 240 | Ubiquitination | DRVYGESKLGGNEIV HHHHCCCCCCHHHHH | 47.01 | 21890473 | |
| 240 | Ubiquitination | DRVYGESKLGGNEIV HHHHCCCCCCHHHHH | 47.01 | 21890473 | |
| 248 | Phosphorylation | LGGNEIVSFLKGLLT CCHHHHHHHHHHHHH | 30.44 | 28857561 | |
| 269 | Methylation | ---------------- ---------------- | - | ||
| 275 | Ubiquitination | ---------------------- ---------------------- | - | ||
| 283 | Phosphorylation | ------------------------------ ------------------------------ | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DPM1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DPM1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ZBT16_HUMAN | ZBTB16 | physical | 16169070 | |
| DPM2_HUMAN | DPM2 | physical | 10835346 | |
| DPM3_HUMAN | DPM3 | physical | 10835346 | |
| CHIP_HUMAN | STUB1 | physical | 16280320 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 608799 | Congenital disorder of glycosylation 1E (CDG1E) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-7 AND SER-9,ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-197, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9 AND SER-21, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-7 AND SER-9,ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9, AND MASSSPECTROMETRY. | |